EZH2 and plasma cell myeloma: In multiple myeloma, MALAT1 positively regulates NRF1 and NRF2 through the transcriptional inhibition of Keap1 by EZH2 [96], which is a component of the PRC that induces H3K27me3 [166] through a mechanism still under study.